Faro Health provides an AI-enabled platform for designing and implementing clinical trial protocols, streamlining the complexities of protocol development through data-driven insights and reusable content. This technology reduces authoring time and enhances the quality of clinical trials, minimizing patient burden and associated costs.
Funding
$38.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinical trial protocol development is a complex and time-consuming process, often leading to delays and increased costs. Traditional methods lack data-driven insights and efficient content reuse, hindering optimization and standardization.
Solution
Faro Health offers an AI-enabled software platform designed to streamline and optimize clinical trial protocol development. The platform leverages data-driven insights and reusable content to accelerate protocol creation, improve quality, and reduce patient burden. By facilitating seamless collaboration and aligning with industry data standards, Faro Health simplifies data system configuration and promotes efficient clinical research. The AI Co-Author feature enables cross-functional study design optimization, generating accurate and consistent protocol documentation.
Target Audience
Faro Health's primary customers are pharmaceutical and biotechnology companies, clinical research organizations (CROs), and academic research institutions involved in clinical trial design and execution.
Features
- AI Co-Author for faster generation of protocol documentation
- Data-driven insights for optimized study design
- Reusable content library for efficient protocol creation
- Seamless collaboration tools for study teams
- Alignment with industry data standards
- Streamlined data system configuration